CFKD-AFN Improves Treatment Prediction via Dual-Channel Knowledge Distillation
September 1, 2026
The CFKD-AFN framework uses low-fidelity simulation data to improve treatment outcome predictions for rare patient groups with scarce high-fidelity trial data. In COPD studies, it reduced mean squared error by up to 74.55% through attention-guided adaptive fusion.
HOW THIS AFFECTS YOU
●
researcherThis provides a method for training high-performance models on small-sample clinical datasets.
●
healthYou can potentially improve precision medicine outcomes for rare diseases where clinical trial data is limited.